Floatz logo

et-01

Transfusion Dependent Beta-Thalassaemia

EdiGene (GuangZhou) Inc.Phase 1Active
C
36/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
21/ 100
Competitive Position
95/ 100

Competitive context

31 Active assets in the Transfusion Dependent Beta-Thalassaemia cohort.

Asset / SponsorPhaseRating
Deferasirox
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
Hydroxyurea
Bahria University
Phase 4BBB
Deferiprone
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB
TACROLIMUS
M.D. Anderson Cancer Center
Phase 4BBB
DESFERRIOXAMINE B
Pakistan Blood and Marrow Transplant (PBMT) Group
Phase 4BBB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →